P649 Does switching to low dose thiopurine and allopurinol prevent IBD patients with evidence of hypermethylation on standard dose thiopurines from developing hepatotoxicity and drug side effects?

Autor:	C. Hovell, K. Slinger, Simon D. McLaughlin, H. Johnson, K. Wade, S. Weaver
Rok vydání:	2017
Předmět:	Thiopurine methyltransferase biology business.industry Low dose Gastroenterology biology.protein Medicine Allopurinol Drug side effects General Medicine Pharmacology business medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 11:S412-S412
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjx002.773
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c146e18d7c40ab922e0e388fbb3b9402 https://doi.org/10.1093/ecco-jcc/jjx002.773 Zobrazit plný text záznamu